Merryn Hall Clinical Oncology Society of Australia Annual Scientific Meeting 2018

Abstracts this author is presenting:

• NUTMEG: A randomised Phase II study of Nivolumab and Temozolomide (TMZ) vs TMZ alone in elderly patients with newly diagnosed Glioblastoma (GBM): Trial in progress   — Poster Session 2